JP2021515789A5 - - Google Patents

Info

Publication number
JP2021515789A5
JP2021515789A5 JP2020548696A JP2020548696A JP2021515789A5 JP 2021515789 A5 JP2021515789 A5 JP 2021515789A5 JP 2020548696 A JP2020548696 A JP 2020548696A JP 2020548696 A JP2020548696 A JP 2020548696A JP 2021515789 A5 JP2021515789 A5 JP 2021515789A5
Authority
JP
Japan
Prior art keywords
treatment system
activator
silicone
transdermal treatment
acrylic hybrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2020548696A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021515789A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/056016 external-priority patent/WO2019175101A1/en
Publication of JP2021515789A publication Critical patent/JP2021515789A/ja
Publication of JP2021515789A5 publication Critical patent/JP2021515789A5/ja
Abandoned legal-status Critical Current

Links

JP2020548696A 2018-03-13 2019-03-11 シリコーンアクリルハイブリッドポリマーを含む経皮治療システム Abandoned JP2021515789A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18161432 2018-03-13
EP18161432.2 2018-03-13
PCT/EP2019/056016 WO2019175101A1 (en) 2018-03-13 2019-03-11 Transdermal therapeutic system comprising a silicone acrylic hybrid polymer

Publications (2)

Publication Number Publication Date
JP2021515789A JP2021515789A (ja) 2021-06-24
JP2021515789A5 true JP2021515789A5 (enExample) 2022-03-22

Family

ID=61628186

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020548696A Abandoned JP2021515789A (ja) 2018-03-13 2019-03-11 シリコーンアクリルハイブリッドポリマーを含む経皮治療システム

Country Status (7)

Country Link
US (1) US20210000756A1 (enExample)
EP (1) EP3764996A1 (enExample)
JP (1) JP2021515789A (enExample)
CN (1) CN111867569A (enExample)
BR (1) BR112020018607A2 (enExample)
CA (1) CA3092775A1 (enExample)
WO (1) WO2019175101A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12048770B2 (en) 2017-10-11 2024-07-30 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone acrylic hybrid polymer
BR112020007011A2 (pt) 2017-10-11 2020-10-06 Lts Lohmann Therapie-Systeme Ag sistema terapêutico transdérmico para a administração transdérmica de guanfacina compreendendo pelo menos um aditivo

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US6974588B1 (en) * 1999-12-07 2005-12-13 Elan Pharma International Limited Transdermal patch for delivering volatile liquid drugs
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
CN101501088B (zh) 2006-06-06 2011-11-30 道康宁公司 有机硅丙烯酸酯混杂组合物
RU2544702C2 (ru) 2009-04-24 2015-03-20 Хенкель Корпорейшн Клеи на основе силикон-акрилового гибридного полимера
JP2013139554A (ja) 2011-11-29 2013-07-18 Dow Corning Corp シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法
EA201491164A1 (ru) 2011-12-12 2014-10-30 ЭлТиЭс ЛОМАНН ТЕРАПИ-ЗЮСТЕМ АГ Трансдермальная система доставки
AU2013205080B2 (en) * 2012-12-12 2016-07-07 Lts Lohmann Therapie-Systeme Ag Transdermal Delivery System
WO2016130408A1 (en) 2015-02-09 2016-08-18 Dow Corning Corporation Multi-phase silicone acrylic hybrid visco-elastic compositions and methods of making same
US20170112781A1 (en) * 2015-10-27 2017-04-27 Noven Pharmaceuticals, Inc. Transdermal drug delivery systems with polyisobutylene face adhesive
US11198800B2 (en) * 2016-07-22 2021-12-14 Lts Lohmann Therapie-Systeme Ag Control of adhesive domains

Similar Documents

Publication Publication Date Title
AU2016215180B2 (en) Pressure-sensitive adhesives for transdermal drug delivery
JPH0474329B2 (enExample)
WO2014062494A1 (en) Compositions and methods for the transdermal delivery of methylphenidate
JP2017519837A (ja) 経皮送達システム
EP0450986B1 (en) A percutaneous-administration-type pharmaceutical preparation of nitroglycerin
JPH0725669B2 (ja) 経皮投与用医薬製剤
JPS60185713A (ja) 経皮吸収性製剤及びその製法
JP2021515789A5 (enExample)
JP2021517572A5 (enExample)
JPS63246325A (ja) ニトログリセリン貼付剤およびその製造方法
JP2021515791A5 (enExample)
JP2021522187A5 (enExample)
CN111867569A (zh) 包含有机硅丙烯酸杂化聚合物的透皮治疗系统
CN111971032A (zh) 包含有机硅丙烯酸杂化聚合物的透皮治疗系统
JPS6066759A (ja) 医薬製剤
JP2021517569A5 (enExample)
JP4255536B2 (ja) 新規貼付剤
JP3233705B2 (ja) 貼付剤
JP2697191B2 (ja) 経皮吸収製剤
JPS5835113A (ja) 複合製剤
JPH06239753A (ja) 抗血栓経皮吸収製剤
JPS6320410B2 (enExample)
CA2934924C (en) Compositions and methods for transdermal delivery of amphetamine
JP2022554147A5 (enExample)
JP4617069B2 (ja) 貼付剤